Hepatology
Cirrhotic Ascites Diuretics
Use sodium restriction and spironolactone-based diuresis for uncomplicated moderate ascites, but stop or de-escalate therapy when renal, neurologic, or electrolyte toxicity emerges. Refractory ascites requires early transition to large-volume paracentesis with albumin, TIPS selection, and transplant evaluation.
Initial branch point
Choose diuretics by ascites severity and immediate risk
The key initial decision is whether ascites is uncomplicated and diuretic-responsive or requires drainage and escalation.
Perform diagnostic paracentesis with ascitic fluid analysis when evaluating ascites; it is a rapid, cost-effective method to establish the cause and detect ascitic fluid infection. Wiley+1WileyManagement of adult patients with ascites due to cirrhosisWileyManagement of adult patients with ascites due to cirrhosis - Runyon A polymorphonuclear neutrophil count of at least 250 cells/mm³ identifies spontaneous bacterial peritonitis in the absence of secondary peritonitis and shifts management away from routine outpatient diuretic titration toward infection-directed treatment and prevention of renal deterioration. NatureNatureImpact of physical activity on clinical outcomes in patients with liver cirrhosis: a prospective observational cohort study | Scientific Reports
Grade 1 ascites, detectable only by ultrasound, requires no ascites-specific treatment. Grade 2 ascites, producing moderate symmetric abdominal distension, should be managed with sodium restriction and diuretics. Grade 3 ascites, with marked abdominal distension, should undergo complete large-volume paracentesis in a single session, followed by sodium restriction and oral diuretics unless ascites is refractory. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Do not treat every increase in abdominal girth as uncomplicated portal-hypertensive ascites. Infection, hepatorenal syndrome, progressive azotemia, clinically important electrolyte disturbance, or hepatic encephalopathy changes the risk-benefit balance against further diuretic escalation. These complications define diuretic-intractable ascites when they preclude effective dosing. aasld+1aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Obtain ascitic fluid cell count to identify neutrocytic ascites; PMN count at least 250 cells/mm³ supports spontaneous bacterial peritonitis. NatureNatureImpact of physical activity on clinical outcomes in patients with liver cirrhosis: a prospective observational cohort study | Scientific Reports
Use large-volume paracentesis rather than attempting slow outpatient diuresis for tense grade 3 ascites. PubMed+1PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Treat new or worsening encephalopathy, renal impairment, or progressive electrolyte imbalance as a diuretic-limiting event. aasld+1aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Outpatient management
Use spironolactone and furosemide to achieve controlled net fluid loss
Titrate to clinical response without exceeding a safe daily rate of weight reduction.
For ascites requiring pharmacologic mobilization, the refractory-ascites ceiling used to judge adequate diuretic exposure is spironolactone 400 mg/day and furosemide 160 mg/day, provided those doses are tolerated; adverse effects frequently prevent reaching those maxima. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD Inability to mobilize ascites despite sodium restriction and maximum tolerated doses supports diuretic-resistant ascites rather than an indication for indefinite dose escalation. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Track body weight as the operational measure of diuretic intensity. During diuretic therapy, target no more than 0.5 kg/day weight loss when peripheral edema is absent and no more than 1 kg/day when edema is present. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC Once ascites has largely resolved, reduce the regimen to the lowest effective dose rather than maintaining high-dose diuresis. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Assess adherence to a sodium-restricted diet before labeling ascites diuretic-resistant. Refractory ascites is defined in part by inability to mobilize fluid despite dietary sodium restriction of 2 g/day and maximum tolerated diuretics. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD Rapid fluid reaccumulation after therapeutic paracentesis despite restriction also meets a refractory pattern and should prompt a procedural strategy rather than repeated medication intensification. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Use spironolactone up to 400 mg/day and furosemide up to 160 mg/day only as tolerated when testing whether ascites is diuretic responsive. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Cap daily weight loss at 0.5 kg without edema and 1 kg with edema. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
After effective mobilization, taper to the lowest diuretic dose that maintains control. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Document 2 g/day dietary sodium restriction before concluding that ascites is diuretic resistant. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Safety surveillance
Stop diuretics when circulatory, renal, neurologic, or sodium complications outweigh natriuresis
Monitoring is intended to identify patients in whom continued diuresis will worsen effective arterial hypovolemia or renal dysfunction.
Reassess renal function, serum sodium, clinical volume status, and encephalopathy during dose adjustment and after any acute decompensating event. Progressive azotemia, hepatic encephalopathy, and progressive electrolyte imbalance are specific diuretic-related complications that establish diuretic-intractable ascites. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD In refractory ascites, permanently discontinue diuretics after diuretic-induced hepatic encephalopathy, renal impairment, or electrolyte abnormalities. easl eueasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
For hypovolemic hyponatremia developing during diuretic therapy, discontinue diuretics and expand plasma volume with normal saline. PubMedPubMedGuidelines on the management of ascites in cirrhosis Restrict fluids to 1 to 1.5 L/day only in clinically hypervolemic patients with severe hyponatremia, defined as serum sodium below 125 mmol/L; routine fluid restriction is not the stated intervention for other ascites states. PubMedPubMedGuidelines on the management of ascites in cirrhosis Reserve 3% hypertonic saline for severely symptomatic acute hyponatremia and correct serum sodium slowly. PubMedPubMedGuidelines on the management of ascites in cirrhosis
Nonselective beta-blocker therapy is not automatically contraindicated by refractory ascites, but identify circulatory failure before maintaining the drug. Continue an otherwise indicated nonselective beta-blocker with close monitoring; reduce the dose or discontinue it when hypotension or acute/progressive renal dysfunction develops. PubMedPubMedGuidelines on the management of ascites in cirrhosis Earlier guidance also advises avoiding high-dose propranolol above 80 mg/day in refractory ascites. easl eueasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Stop diuretics and give normal saline for hypovolemic hyponatremia during diuretic therapy. PubMedPubMedGuidelines on the management of ascites in cirrhosis
Use fluid restriction of 1 to 1.5 L/day only for hypervolemic severe hyponatremia with sodium below 125 mmol/L. PubMedPubMedGuidelines on the management of ascites in cirrhosis
Use 3% saline only for severely symptomatic acute hyponatremia, with slow correction. PubMedPubMedGuidelines on the management of ascites in cirrhosis
Reduce or stop nonselective beta-blockers if hypotension or acute/progressive renal dysfunction develops. PubMedPubMedGuidelines on the management of ascites in cirrhosis
| Complication | Threshold or pattern | Immediate diuretic action |
|---|---|---|
| Hypovolemic hyponatremia | Occurs during diuretic therapy. PubMedPubMedGuidelines on the management of ascites in cirrhosis | Discontinue diuretics and expand plasma volume with normal saline. PubMedPubMedGuidelines on the management of ascites in cirrhosis |
| Hypervolemic severe hyponatremia | Serum sodium below 125 mmol/L. PubMedPubMedGuidelines on the management of ascites in cirrhosis | Restrict fluids to 1-1.5 L/day. PubMedPubMedGuidelines on the management of ascites in cirrhosis |
| Severely symptomatic acute hyponatremia | Acute symptoms requiring urgent sodium correction. PubMedPubMedGuidelines on the management of ascites in cirrhosis | Reserve 3% hypertonic saline; correct sodium slowly. PubMedPubMedGuidelines on the management of ascites in cirrhosis |
| Encephalopathy, renal impairment, or electrolyte abnormalities attributable to diuretics | Diuretic-induced complication in refractory ascites. easl eueasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL | Discontinue diuretics permanently. easl eueasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL |
When diuretics should not be restarted automatically
After a diuretic-induced complication, restart only if a meaningful natriuretic response is expected and treatment can be tolerated. In refractory ascites, continuation is supported only when urinary sodium excretion on treatment exceeds 30 mmol/day; otherwise, repeated large-volume paracentesis with albumin becomes the preferred fluid-control strategy. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Failure of diuresis
Use paracentesis with albumin first, then select TIPS and transplant pathways
Refractory ascites is a prognostic transition that should trigger procedural and transplant planning.
Refractory ascites carries poor short-term prognosis, with reported survival of 50% at 6 months and 25% at 1 year. aasldaasldManagement of Refractory Ascites in Cirrhosis | AASLD It should therefore trigger evaluation beyond repeated outpatient diuretic changes, including candidacy for TIPS and liver transplantation. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLBMJGuidelines on the management of ascites in cirrhosis - Gut
Repeated large-volume paracentesis plus albumin at 8 g per liter of ascites removed is first-line therapy for refractory ascites. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL Large-volume paracentesis is safe and effective, with lower incidence of renal injury and electrolyte abnormalities and fewer systemic and hemodynamic disturbances than diuretics in the cited synthesis. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC Continue using this approach when TIPS is contraindicated or deferred.
Consider TIPS for refractory ascites, recurrent ascites, very frequent need for large-volume paracentesis, or ineffective paracentesis such as loculated ascites. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL TIPS improves ascites control, but hepatic encephalopathy is an important tradeoff. easl eueasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL Use caution when age exceeds 70 years, bilirubin exceeds 50 µmol/L, platelet count is below 75 × 10^9/L, MELD score is at least 18, or the patient has current hepatic encephalopathy, active infection, or hepatorenal syndrome. BMJBMJGuidelines on the management of ascites in cirrhosis - Gut
After TIPS, continue sodium restriction and diuretics until ascites resolves, with close clinical follow-up. easl eueasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ... Where TIPS is selected, small-diameter PTFE-covered stents are recommended to reduce shunt dysfunction and to reduce hepatic encephalopathy risk in patients at high risk for encephalopathy. easl eueasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Use albumin 8 g/L of removed ascites with repeated large-volume paracentesis for refractory ascites. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Consider TIPS when paracentesis is required very frequently or is ineffective because of loculated ascites. easl eueasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Use heightened caution before TIPS for MELD at least 18, bilirubin above 50 µmol/L, age above 70 years, active infection, hepatorenal syndrome, current encephalopathy, or platelets below 75 × 10^9/L. BMJBMJGuidelines on the management of ascites in cirrhosis - Gut
Evaluate refractory or recurrent ascites for liver transplantation. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Role of adjunctive vasoconstrictor therapy
Midodrine may be considered case by case in refractory ascites. PubMedPubMedGuidelines on the management of ascites in cirrhosis An oral dose of 7.5 mg three times daily has been reported as beneficial when added to standard diuretic therapy, but this should not substitute for paracentesis, TIPS selection, or transplant evaluation when ascites remains refractory. PubMedPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Longitudinal management
Reassess response after every decompensating event and avoid futile diuretic exposure
Ascites management should move promptly between diuretic-responsive and refractory pathways.
At each follow-up, document weight trajectory, peripheral edema, abdominal fluid burden, serum sodium, renal function, neurologic status, and urine sodium response when refractory ascites is being considered. A urine sodium excretion threshold above 30 mmol/day on diuretics distinguishes patients in whom maintenance diuretics may still be considered from those in whom they should be stopped. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
When ascites has largely resolved, use the lowest effective diuretic dose and continue sodium restriction rather than preserving prior high doses. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC When ascites recurs rapidly despite dietary restriction, medication escalation should not delay referral for serial large-volume paracentesis, TIPS assessment, and transplant evaluation. aasld+2aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
For patients receiving nonselective beta-blockers, reassess blood pressure and kidney function concurrently with ascites therapy. Refractory ascites alone does not require beta-blocker discontinuation, but hypotension or acute/progressive renal dysfunction does. PubMedPubMedGuidelines on the management of ascites in cirrhosis
Use urine sodium greater than 30 mmol/day on treatment as the criterion supporting continued diuretics in refractory ascites. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Reduce diuretics after ascites control rather than maintaining the dose used for initial mobilization. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Escalate rapidly recurrent ascites to serial paracentesis, TIPS assessment, and transplant evaluation. aasld+2aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
References
- Effect of Intravenous Albumin on Renal Impairment and Mortality in ... — www.nejm.org · www.nejm.org
- Diagnosis, prevention and treatment of hepatorenal syndrome ... - Gut — gut.bmj.com · gut.bmj.com
- Guidelines on the management of ascites in cirrhosis - Gut — gut.bmj.com · gut.bmj.com
- Recent advances in the prevention and treatment of decompensated ... — gut.bmj.com · gut.bmj.com
- Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement | Nature Reviews Clinical Oncology — www.nature.com · www.nature.com
- Optimizing the liver transplant candidate | npj Gut and Liver - Nature — www.nature.com · www.nature.com
- Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study | Scientific Reports — www.nature.com · www.nature.com
- Impact of physical activity on clinical outcomes in patients with liver cirrhosis: a prospective observational cohort study | Scientific Reports — www.nature.com · www.nature.com
- Clinical Features of Refractory Ascites in Outpatients — www.sciencedirect.com · www.sciencedirect.com
- Management of cirrhotic ascites: Seven‐step treatment protocol ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- The North American Study for the Treatment of Refractory Ascites - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Ascites and Spontaneous Bacterial Peritonitis - Novel Coronavirus — novel-coronavirus.onlinelibrary.wiley.com · novel-coronavirus.onlinelibrary.wiley.com
- Management of adult patients with ascites due to cirrhosis — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Spontaneous bacterial peritonitis in asymptomatic outpatients with ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- SHM Converge 2026 Abstracts - Society of Hospital Medicine - Wiley — shmpublications.onlinelibrary.wiley.com · shmpublications.onlinelibrary.wiley.com
- Management of adult patients with ascites due to cirrhosis - Runyon — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Cirrhotic refractory ascites: Pathogenesis, current therapeutic strategies, and future directions — www.sciencedirect.com · www.sciencedirect.com
- [PDF] EASL Clinical Practice Guidelines for the management of patients ... — easl.eu · easl.eu
- Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL — easl.eu · easl.eu
- Management of Refractory Ascites in Cirrhosis | AASLD — www.aasld.org · www.aasld.org
- Guidelines on the management of ascites in cirrhosis — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov